Nanoparticles in Tissue Engineering
A special issue of Future Pharmacology (ISSN 2673-9879).
Deadline for manuscript submissions: 31 December 2024 | Viewed by 236
Special Issue Editors
Interests: materials chemistry; polymer chemistry; nanotechnology; nanoscience; nanomedicine; biomaterials; environmental science; environmental chemistry
Interests: peptide chemistry; organic chemistry; chelating agents; imaging probes; computational chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nowadays, climate change, incredible growth of population and animal production, energy consumption, and various other transformations input the human research from diverse frontiers in search for sustainability and economic and social life more adequately. In this sense, nanotechnology appears to be an incredible solution for diverse areas. Nanotechnology is highlighted for use in pharmaceutical products as well as in other production fields, such as systems used to transport molecules of therapeutic interest. At this juncture, different types of nanoparticles have been produced, including polymeric nanoparticles, which have attracted more attention due to their therapeutic potential and better stability in biological fluids and in the storage of drugs. In addition, there are also magnetic nanoparticles, which have a wide range of actions, such as hyperthermia and disease diagnosis, among others. Furthermore, due to its range of applications, nanotechnology presents a multidisciplinary approach, as it involves aspects of physics, chemistry, biology, mathematics, and engineering. Thus, considering the high importance of producing innovative materials for sustainable development in the world and the proposal to promote improvement in the quality human life, this Special Issue proposes interdisciplinary research in the use of nanoparticles in tissue engineering.
We are pleased to invite you to contribute your ideas, insights, and perspectives from the dynamic landscape of nanoparticles for tissue engineering, covering a wide range of topics related to the following areas, among others: hyperthermia, disease diagnosis and interactions with the biological environment, biocompatibility and safety assessments, clinical applications, treatment, therapeutics, cosmetics, drug delivery, transport molecules of therapeutic interest, and translational research.
This Special Issue aims to detail all research in the area of nanoparticles in tissue engineering associated with the pharmaceutical area, such as drug delivery, therapeutics, cosmetics, transport molecules of therapeutic interest, diagnosis, interactions with the biological environment, biocompatibility and safety assessments, clinical applications, and uses of drug-free formulations in the treatment of diverse diseases. Thus, this Special Issue can contribute to diverse areas of pharmaceuticals in the global issue of tissue engineering. In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Prof. Dr. Fernanda Guerra Lima Medeiros Borsagli
Dr. Giuseppe Floresta
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- nanoparticles in controlled drug delivery
- biomaterials
- lipid nanoparticles
- polymeric nanoparticles
- inorganic nanoparticles
- localized administration routes
- targeted/triggered drug delivery
- biocompatibility
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
